Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence study of generic fluticasone propionate versus FLOVENT DISKUS in asthma
2020-002977-84Phase 3Completed
- Sponsor
- Respirent Pharmaceuticals Co. Ltd.
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of fluticasone propionate nasal spray and fluticasone propionate in asthma (2 arms), sponsored by Respirent Pharmaceuticals Co. Ltd. Primary endpoint: Pre-dose FEV1. Started Sep 2020; status: completed.
02
Drugs
fluticasone propionate nasal sprayfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2020-002977-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002977-84.